DKSH Enters Exclusive Distribution Agreement with Lactalis in Asia and Europe

Zurich, Switzerland, March 1, 2024 – DKSH’s Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, will provide business development, marketing, sales, logistics, and distribution services for Lactalis’ pharmaceutical-grade lactose for customers producing Finished Dosage Forms (FDFs), including tablets, pills, capsules, liquid solutions, among others in Bangladesh, India, Indonesia, Thailand, Portugal, and Spain.

Lactalis provides high-purity pharmaceutical lactose to formulate oral solid dose medicines, conforming with the lactose monohydrate monograph of the current Pharmacopoeia (Ph. Eur., USP-NF, and JP). 

DKSH has been entrusted to grow Lactalis’ pharmaceutical business across the six key markets in Asia and Europe thanks to its extensive distribution network, knowledgeable commercial and technical teams, strong capabilities in logistics, and its valued services, including innovation and formulation and market research and analysis.

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, Performance Materials, DKSH, commented: “We are very pleased to sign an exclusive distribution agreement with Lactalis in Asia and Europe. Our deep market insights and a broad range of services in the region will enable us to increase growth for Lactalis’ pharmaceutical-grade lactose and generate more value for our wide customer base in the pharmaceutical industry. We are confident that our use of traditional and digital distribution and marketing channels will deliver exceptional results.”